The US Food and Drug Administration gave clearance recently for a wearable device whose software capabilities are designed to detect early signs of infection.
Risk factors change depending on time from diagnosis and comorbidities, however.
73% of hospitals have a committee that monitors and reviews sepsis care, with prevalence varying by hospital size.
A recent study evaluated where diagnostic error occurs most frequently in the US, and concluded that there is a need to develop new “systematic solutions,”
The US Food and Drug Administration approved use of AI-powered sepsis detection software last week, part of a slew of recent innovations from South Korea.
No improvement was seen in the composite of all-cause mortality and the emergence of pandrug- or extensively drug-resistant bacteria.
A small reduction in mortality was seen with use of hydrocortisone with fludrocortisone.
Compared with hydrocortisone alone, the combo significantly cuts the risk for in-hospital death or hospice discharge.
“Professionals need to be aware that people who have previously had sepsis are at very high risk for cardiovascular events,” an author said.
Patients whose alert was confirmed by a provider within three hours had a reduced in-hospital mortality rate.
Please login or register first to view this content.